Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 12:06 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 5.800% |
-36,000 (-1.35%) |
Filing History |
| 2022-02-14 12:03 pm Purchase |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Matrix Capital Management Company, LP | 4,349,279 9.600% |
527,540 (+13.80%) |
Filing History |
| 2022-02-10 5:07 pm Purchase |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Zentalis Pharmaceuticals Inc. ZNTL |
2,859,377 6.200% |
2,859,377 (New Position) |
Filing History |
| 2022-02-10 08:47 am Purchase |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 3,186,986 7.030% |
840,849 (+35.84%) |
Filing History |
| 2022-02-09 10:04 am Purchase |
2022-02-08 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 6,795,831 14.999% |
703,753 (+11.55%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
BLACKROCK INC BLK |
2,842,945 6.300% |
567,796 (+24.96%) |
Filing History |
| 2022-02-01 3:33 pm Purchase |
2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 3,022,790 6.700% |
3,022,790 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 1,503,870 3.700% |
-626,094 (-29.39%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Redmile Group LLC | 2,416,406 6.000% |
2,416,406 (New Position) |
Filing History |
| 2021-02-16 10:02 am Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Matrix Capital Management Company, LP | 3,821,739 9.410% |
3,821,739 (New Position) |
Filing History |
| 2021-02-12 7:52 pm Sale |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
VIKING GLOBAL INVESTORS LP | 3,011,284 7.400% |
-1,432,000 (-32.23%) |
Filing History |
| 2021-02-10 12:04 pm Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
The Vanguard Group | 2,346,137 5.780% |
2,346,137 (New Position) |
Filing History |
| 2021-02-08 10:35 am Purchase |
2021-02-05 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 6,092,078 14.999% |
1,085,906 (+21.69%) |
Filing History |
| 2021-02-03 5:27 pm Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
SUN ANTHONY Y | 2,991,907 7.300% |
2,991,907 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
BLACKROCK INC BLK |
2,275,149 5.600% |
2,275,149 (New Position) |
Filing History |
| 2020-11-10 10:27 am Purchase |
2020-11-09 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
FMR CORP | 5,006,172 12.323% |
5,006,172 (New Position) |
Filing History |
| 2020-05-29 09:21 am Purchase |
2020-05-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 7.400% |
2,664,409 (New Position) |
Filing History |